Venture Medical is a company that develops wound healing and regenerative medicine products. Its filings show it lobbied on Medicare and Medicaid coverage and payment rules for human cell and tissue products, including efforts related to the Skin Substitute Access and Payment Reform Act of 2025 and amendments to Medicare (Title XVIII). It used The McManus Group for this work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEX WHALEN
The latest disclosures for this client.
THE MCMANUS GROUP
Q2THE MCMANUS GROUP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE MCMANUS GROUP
JOHN MCMANUS
THE MCMANUS GROUP
THE MCMANUS GROUP
RR